RT Journal Article
SR Electronic
T1 A randomised clinical trial to assess the effect of active muscle stimulation on hospitalised patients with COPD exacerbations
JF European Respiratory Journal
JO Eur Respir J
FD European Respiratory Society
SP P4775
VO 40
IS Suppl 56
A1 Timm Greulich
A1 Maja Franke
A1 Juliane Fechtel
A1 Christoph Nell
A1 Katharina Kehr
A1 Silke Mueller
A1 Harald Schubert
A1 Klaus Kenn
A1 Claus Vogelmeier
A1 Andreas Rembert Koczulla
YR 2012
UL http://erj.ersjournals.com/content/40/Suppl_56/P4775.abstract
AB Introduction:Physical exercise reduces the detrimental effects of acute exacerbations in patients with chronic obstructive pulmonary disease (COPD). The Galileo™ system (Novotec Medical, Pforzheim, Germany) is based on the principle of active muscle contraction via extension reflex triggers.Aim:To assess the effect of active muscle stimulation in hospitalised COPD patients on exercise capacity, health-related quality of life (Qol), and inflammation.Methods:24 hospitalised COPD patients with an acute exacerbation were randomised to participate either in the standard physiotherapy programme (PT: physical and respiratory exercises) or in the standard programme with the addition of exercises on the Galileo device (PTG). On the days of admission and discharge we assessed: 6-minute walking test (6-MWT), COPD assessment test (CAT), and serum c-reactive protein (CRP).Results:The baseline characteristics are shown in table 1.View this table:While CRP decreased in both groups (p<0.05), we found a significant increase in the 6-MWT (p<0.005) and a significant decrease in the CAT (p<0.05) in the PTG group only (table 2).View this table:Conclusion:In patients hospitalised due to an exacerbation of COPD, the addition of active muscle contraction with the Galileo system results in beneficial effects on Qol and exercise capacity.